![](/img/cover-not-exists.png)
PCSK9 Inhibitors and Neurocognitive Adverse Events: Exploring the FDA Directive and a Proposal forN-of-1 Trials
Swiger, Kristopher J., Martin, Seth S.Volume:
38
Language:
english
Journal:
Drug Safety
DOI:
10.1007/s40264-015-0296-6
Date:
June, 2015
File:
PDF, 743 KB
english, 2015